Vaxart (VXRT) announced that it will present research featuring its COVID-19 and norovirus oral pill vaccine candidates at the World Vaccine ...

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it will present research featuring its COVID-19 and norovirus oral pill vaccine ...

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it will present research featuring its COVID-19 and norovirus oral pill vaccine ...

On Monday, Vaxart Inc (VXRT) stock saw a decline, ending the day at $0.78 which represents a decrease of $-0.04 or -4.88% from the prior close of $0.82. The stock opened at $0.81 and touched a low of ...

400 subject sentinel portion of Phase 2b study will evaluate the safety, immunogenicity and efficacy of Vaxart’s next generation oral pill COVID-19 vaccine compared to an approved mRNA vaccine ...

On Friday, Vaxart Inc (VXRT) stock saw a modest uptick, ending the day at $0.82 which represents a slight increase of $0.01 or 1.23% from the prior close of $0.81. The stock opened at $0.8 and touched ...

Vaxart, Inc. (NASDAQ:VXRT – Get Free Report) crossed below its two hundred day moving average during trading on Thursday .The stock has a two hundred day moving average of $0.83 and traded as ...

Option chain shows key data for Vaxart's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Vaxart.

SOUTH SAN FRANCISCO, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it will present research demonstrating the potential of its norovirus oral pill vaccine ...